Oxford, June 26th, 2007 - Oxford Gene Technology (OGT) and Ocean
Ridge Biosciences (ORB) are pleased to announce the completion of a
licence agreement granting ORB access to one of OGT’s “Southern
array patents”, the fundamental patents covering the manufacture and
marketing of oligonucleotide microarrays.
The granted license will enable ORB to offer complete DNA expression
and microRNA profiling services, worldwide, from its US operations
in Jupiter, Florida.
Sue Sutton, Vice President Licensing North America, at OGT said:
“Successful discussions with ORB have concluded with the granting of
this license thus enabling the company to expand their customer base
and add to OGT’s growing portfolio of North American licensees.”
Senior Scientist at ORB, David Willoughby, Ph.D. is pleased with the
progress of the biotechnology company, commenting: “We appreciate
the opportunity to provide this fundamental invention of Edwin
Southern to the general research community, both locally here in
Florida and throughout the U.S. and Canada. The licence will enable
us to continue with our mission of improving human health through
the provision of accurate, affordable, and information-rich genomic
services.”
The licence will remain valid for the patents’ lifetime. Financial
details were not disclosed.
- ENDS -
For further information, please contact:
At Oxford Gene Technology:
Nicola Booton-Mander, Marketing Manager
Oxford Gene Technology
Begbroke Science Park,
Sandy Lane, Yarnton
Oxford OX5 1PF
T: +44 1865 856352
F: +44 1865 842116
E: licensing@ogt.co.uk
W: www.ogt.co.uk
Media Enquiries:
Annabel Entress, 0207 268 3002 /
a.entress@northbankcommunications.com
Sarah Jeffery, 0207 268 3002 /
s.jeffery@northbankcommunications.com
At Ocean Ridge Biosciences:
Becky A. Mercer, Ph.D. Director of Marketing
Ocean Ridge Biosciences
150 S. Old Dixie Highway
Jupiter, FL 33458
T: 203-464-2037
F: 561-575-4118
E:
bmercer@oceanridgebio.com
W: http://oceanridgebio.com/
Notes to editors
About Oxford Gene Technology
Founded in 1995 by the pioneer of Southern Blotting, Professor Sir
Edwin Southern, OGT operates out of Begbroke Business Park near
Oxford, with excellent access to a growing network of life science
companies
· OGT offers a comprehensive custom microarray consultancy service,
from experimental design through all stages to data analysis and
interpretation. It has a strong proven track record in providing
custom microarray service in a range of applications, and recently
announced the launch of its first microarray product, an Escherichia
coli K12 ChIP on chip, the first ChIP microarray product to be
launched as part of OGT’s Prokaryotic Chip2 family
The key focus areas of OGT include:
1. Array-based application products and services for life science
research and molecular diagnostics. OGT’s flexible and
cost-effective, customised DNA microarray service covers a range of
applications, offering specialist support and assisting customers
with every aspect of their research, from initial consultation and
experimental design to probe selection, array design and fabrication
through to data analysis and interpretation.
2. Development of innovative platform products for clinical research
and diagnostics
3. Licensing. OGT operates an open licensing policy which has
successfully provided access for a number of companies to OGT's
fundamental intellectual property, particularly in the area of
microarrays
4. Scientific collaborations to generate diagnostic biomarker
intellectual property
For further information on OGT visit
http://www.ogt.co.uk/
About Ocean Ridge Biosciences
Ocean Ridge Biosciences (ORB), a limited liability company based in
Jupiter, Florida, was founded in 2005 with a mission to improve
human health through the provision of accurate, affordable, and
information-rich genomic services. ORB currently provides gene
expression profiling services to both industrial and academic
clients including researchers based at the University of Miami,
Florida Atlantic University, The Scripps Research Institute in
Florida, the University of Arkansas, and Columbia University in New
York.
ORB is the first commercial provider to offer expression profiling
utilizing open-source Exonic Evidence-Based Oligonucleotide Arrays (HEEBO/
MEEBO). The HEEBO/MEEBO oligo sets were designed by an international
consortium lead by Ash Alizadeh of Stanford University and feature
well-designed controls for specificity and sensitivity as well as
unique coverage of alternatively spliced transcripts. In addition to
standard expression, ORB also provides a microRNA profiling service
utilizing a proprietary hybridisation process that facilitates
excellent sensitivity and reproducibility. Complete data analysis is
included with all of ORB’s profiling services.
|
